EdwardRGouldMD
Nephrology • Nashville, TNChronic Renal Failure & Dialysis, Glomerular Disease, Hypertension
Assistant Professor of Nephrology Division of Nephrology Vanderbilt University Medical Center
Dr. Gould is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Summary
- Dr. Edward Gould is a nephrologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from State University of New York Upstate Medical University and has been in practice 8 years. He specializes in chronic renal failure & dialysis, glomerular disease, and hypertension and is experienced in hypertension, general nephrology, acute renal failure, chronic kidney disease, and nephrolithiasis.
Education & Training
Vanderbilt University Medical CenterFellowship, Nephrology, 2013 - 2015- Vanderbilt University Medical CenterChief Residency, Internal Medicine, 2012 - 2013
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2009 - 2012
SUNY Upstate Medical UniversityClass of 2009
Certifications & Licensure
TN State Medical License 2012 - 2025
AL State Medical License 2020 - 2020- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 3 citationsKidney collecting duct cells make vasopressin in response to NaCl-induced hypertonicity.Juan Pablo Arroyo, Andrew S Terker, Yvonne Zuchowski, Jason A Watts, Fabian Bock
JCI Insight. 2022-12-22 - 172 citationsMechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular DiseaseArvind K. Pandey, Eric K. Singhi, Juan Pablo Arroyo, Talat Alp Ikizler, Edward R. Gould
Hypertension. 2018-02-01 - 5 citationsePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyper...Gema Ariceta, Laure Collard, Saoussen Abroug, Shabbir H Moochhala, Edward Gould
Pediatric Nephrology. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
